Literature DB >> 8870639

Human parvovirus B19 infection within a family and risk for pregnant women.

A Azzi1, M Trotta, K Zakrzewska, E Balzer, P G Rogasi, A Carocci, F Leoncini.   

Abstract

During an outbreak of parvovirus B19 infection among four related families at least 70% of the household contacts, including a woman at the 33rd week of pregnancy, became infected. Twins were born at the 39th week of pregnancy, both with B19 infection. B19 DNA was detected in their sera by a nested PCR, anti-B19 IgM was detectable only by an immunofluorescence assay, and low levels of maternal anti-B19 IgG were demonstrable by an immunoenzymatic test in the serum of both children. All the haematological parameters were normal at birth and 6 months later, when B19 DNA and anti-B19 antibody were no longer detectable in serum samples. This observation emphasizes the high risk of B19 infection among household contacts and the possibility of a favourable outcome of the foetal infection, possibly related to infection late in the pregnancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870639      PMCID: PMC2271698          DOI: 10.1017/s095026880000159x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  14 in total

1.  Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates.

Authors:  O Bartolomei Corsi; A Azzi; M Morfini; R Fanci; P Rossi Ferrini
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

2.  Human parvovirus B19.

Authors:  J R Pattison
Journal:  BMJ       Date:  1994-01-15

3.  Human parvovirus infection in pregnancy and hydrops fetalis.

Authors:  A Anand; E S Gray; T Brown; J P Clewley; B J Cohen
Journal:  N Engl J Med       Date:  1987-01-22       Impact factor: 91.245

Review 4.  Parvovirus B19 infection in pregnancy.

Authors:  T F Schwarz; A Nerlich; M Roggendorf
Journal:  Behring Inst Mitt       Date:  1990-08

5.  Risk of infection following exposures to human parvovirus B19.

Authors:  L J Anderson; S M Gillespie; T J Torok; E S Hurwitz; C J Tsou; G W Gary
Journal:  Behring Inst Mitt       Date:  1990-08

6.  Human parvovirus B19 infection among hospital staff members after contact with infected patients.

Authors:  L M Bell; S J Naides; P Stoffman; R L Hodinka; S A Plotkin
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

7.  Aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia.

Authors:  A Azzi; P A Macchia; C Favre; M Nardi; K Zakrzewska; O B Corsi
Journal:  Haematologica       Date:  1989 Mar-Apr       Impact factor: 9.941

8.  Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction.

Authors:  K Zakrzewska; A Azzi; G Patou; M Morfini; D Rafanelli; J R Pattison
Journal:  Br J Haematol       Date:  1992-07       Impact factor: 6.998

9.  Experimental parvoviral infection in humans.

Authors:  M J Anderson; P G Higgins; L R Davis; J S Willman; S E Jones; I M Kidd; J R Pattison; D A Tyrrell
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

10.  Congenital anaemia after transplacental B19 parvovirus infection.

Authors:  K E Brown; S W Green; J Antunez de Mayolo; J A Bellanti; S D Smith; T J Smith; N S Young
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321

View more
  1 in total

1.  Risk of transmission of severe acute respiratory syndrome to household contacts by infected health care workers and patients.

Authors:  Louis Y Chan; John T W Wong; Philip K T Li; S F Lui; Hong Fung; Joseph Sung
Journal:  Am J Med       Date:  2004-04-15       Impact factor: 4.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.